Estadístiques de First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN

Visites totals

views
First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN 4

Visites totals per mes

views
January 2025 0
February 2025 0
March 2025 3
April 2025 0
May 2025 0
June 2025 1
July 2025 0

Visites al fitxer

views
Martinez_bcr_firs.pdf 41